| Literature DB >> 20571971 |
Andrew J Thorpe1, James Offord.
Abstract
Currently, there are two drugs on the market, gabapentin (Neurontin) and pregabalin (Lyrica), that are proposed to exert their therapeutic effect through binding to the alpha2-delta subunit of voltage-sensitive calcium channels. This activity was unexpected, as the alpha2-delta subunit had previously been considered not to be a pharmacological target. In this review, the role of the alpha2-delta subunits is discussed and the mechanism of action of the alpha2-delta ligands in vitro and in vivo is summarized. Finally, new insights into the mechanism of drugs that bind to this protein are discussed.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20571971
Source DB: PubMed Journal: Curr Opin Investig Drugs ISSN: 1472-4472